NUVB
Nuvation Bio Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +9.1% ·
share flow +30.0% ·
net new positions +8.3%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 82.70K | $409,370 | n/a | n/a |
| Q2 2026 | 97 | +2 | 157.38M | $893.56M | +5 | −3 |
| Q1 2026 | 98 | +3 | 147.71M | $634.66M | +12 | −9 |
| Q4 2025 | 94 | +2 | 141.34M | $1.26B | +2 | n/a |
| Q3 2025 | 19 | +1 | 120.52M | $443.85M | +2 | −1 |
| Q2 2025 | 15 | 0 | 120.03M | $233.06M | +1 | −1 |
| Q1 2025 | 12 | -1 | 18.55M | $32.01M | n/a | −1 |
| Q4 2024 | 13 | 0 | 18.40M | $47.86M | n/a | n/a |
| Q3 2024 | 12 | +1 | 12.76M | $28.26M | +1 | n/a |
| Q2 2024 | 11 | n/a | 9.41M | $26.24M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 4.03M | +5.1% | $9.23M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 2 | Citadel Advisors ✦ | 2.83M | +36.5% | $6.32M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 3 | Millennium Management ✦ | 1.35M | +220.8% | $3.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Two Sigma Investments ✦ | 1.15M | +7.1% | $2.62M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 1.03M | +35.2% | $2.36M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 742.44K | +565.4% | $1.70M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 7 | Wellington Management ✦ | 623.97K | +83.3% | $1.43M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 8 | Point72 Asset Management ✦ | 276.71K | New | $633,675 | 0.0% | New | 1 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 215.27K | -2.3% | $493,000 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 111.23K | -35.3% | $254,710 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 11 | Greenlight Capital (DME Capital) ✦ | 135.00K | 0.0% | $89,929 | 0.0% | Held | 2 | SEC ↗ ×2 |
| 12 | Adage Capital Partners ✦ | 266.67K | 0.0% | $26,107 | 0.0% | Held | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $633,675 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 230 holders, 219.97M shares, $906.24M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 100.00K sh · $709,240
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology